Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
3 Reasons to Retain Baxter (BAX) Stock in Your Portfolio
04:29pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Investors remain optimistic about Baxter (BAX) due to its strong product portfolio.
These Are The Top 10 Holdings Of Larry Robbins
08:02pm, Tuesday, 11'th Oct 2022
Larry Robbins is the founder and CEO of Glenview Capital Management, which is a New York-based hedge fund.
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
04:19pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.
Thermo Fisher (TMO) Launches New TaqPath Panel in Europe
03:19pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
This panel of Thermo Fisher (TMO), apart from detecting GI bacteria, also helps in identifying the root cause of an infection and administering the best suitable treatment fast.
Charles River's (CRL) New Launch to Boost Gene Therapy Workflow
02:22pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
Charles River's (CRL) latest product offering is expected to streamline the pathway to GMP AAV vector manufacturing without significant process development.
4 Defensive Bets to Pacify Pessimists to Ride Market Storms
12:52pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
Here we mention four defensive stocks, namely Lamb Weston (LW), Consolidated Water, McKesson and Hershey with strong prospects to stay afloat in the bear market.
4 Defensive Bets to Pacify Pessimists to Ride Market Storms
10:32am, Tuesday, 11'th Oct 2022
Here we mention four defensive stocks, namely Lamb Weston (LW), Consolidated Water, McKesson and Hershey with strong prospects to stay afloat in the bear market.
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
03:56pm, Monday, 10'th Oct 2022 Zacks Investment Research
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
Walgreens (WBA) to Report Q4 Earnings: What's in the Cards?
01:57pm, Monday, 10'th Oct 2022 Zacks Investment Research
Walgreens (WBA) is expected to have registered growth in Q4 in its U.S. retail pharmacy business, banking on demand for vaccinations and tests amid the ongoing series of contagious virus spread.
Warren Buffett's Buying This Passive Income Stock
12:53pm, Saturday, 08'th Oct 2022 The Motley Fool
You should have this blue chip healthcare stock on your radar.
Warren Buffett's Buying This Passive Income Stock
08:53am, Saturday, 08'th Oct 2022
You should have this blue chip healthcare stock on your radar.
McKesson (MCK) Stock Moves -1.2%: What You Should Know
10:00pm, Friday, 07'th Oct 2022 Zacks Investment Research
McKesson (MCK) closed at $346.68 in the latest trading session, marking a -1.2% move from the prior day.
Edwards Lifesciences (EW) TAVR Sales Strong Amid Macro Issues
05:41pm, Friday, 07'th Oct 2022 Zacks Investment Research
Edwards Lifesciences (EW) expects full-year 2022 underlying sales growth in the mid-single-digit range on the back of strength in demand for products used in more intense surgeries.
Reasons to Retain Veeva Systems (VEEV) Stock in Your Portfolio
05:26pm, Friday, 07'th Oct 2022 Zacks Investment Research
Veeva Systems' (VEEV) slew of strategic deals raises optimism about the stock.
Neogen (NEOG) Q1 Earnings Top Estimates, Operating Margin Dips
05:16pm, Friday, 07'th Oct 2022 Zacks Investment Research
Neogen's (NEOG) allergen and environmental sanitation product lines decline due to reduced buying patterns from customers and supply chain disruptions of certain products.
